Speaking on the likely deal with the European Commission for the supply of millions of doses for a price below $25 per dose, the CEO said, "Nothing is signed yet, but we're close to a deal with the EU Commission". On 11 August, Russia became the first country in the world to register a coronavirus vaccine , dubbed Sputnik V. The vaccine, which is based on a human adenoviral vector platform, was... [Full Article...]
Excitingly, one of our dosing regimens may be around 90% effective, " said Andrew Pollard, the chief investigator for the trial. Before Pfizer , Moderna and Astra Zeneca shared their results, Gallup Economics conducted a poll with Franklin-Templeton on what it would take for Americans to be willing to get a COVID-19 vaccine. [Full Article...]
David Eyre , an infectious disease consultant at Oxford and one of the study authors, said on Twitter "it's very unlikely, at least for 6 months", that people can become reinfected with COVID-19. Of the remaining workers who did not have antibodies, 89 tested positive for the coronavirus . "We know from a previous study that antibody levels fall over time, but this latest study shows that t... [Full Article...]
An ICMR scientist told Reuters earlier this month the vaccine could be launched in February or March, although Bharat Biotech separately told Reuters on Friday that results of the late-stage trials were expected only between March and April. [Full Article...]
Bureaucracy, civil society representatives, parliamentarians, media and child rights activist joined hands to celebrates this year's Universal Children's day and draw the attention of key stakeholders including parents, government , parliamentarians and policy makers to work together on the issues of child rights and stressed on the need to take appropriate measures. [Full Article...]
Once a vaccine receives emergency use authorization, the Operation Warp Speed program will begin shipping vaccines to distribution centers across the U.S. On 11 August, Russia became the first country in the world to register a coronavirus vaccine, dubbed Sputnik V. The vaccine, which is based on a human adenoviral vector platform, was developed by the Gamaleya Research Institute of Epidemiology... [Full Article...]
People who've had COVID-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of fight against the coronavirus pandemic. However, most studies indicated that patients without symptoms still have two key advantages: they may be able to clear the virus faster from their body, and they c... [Full Article...]
Regeneron's REGEN-COV2 "antibody cocktail" - containing an antibody made by the company and a second isolated from humans who recovered from Covid-19 - is designed so that the two antibodies seek out and bind to the coronavirus' spike protein to prevent it from entering healthy human cells. [Full Article...]